Profound Medical Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	50.3	59.72	54.91	26.21	46.52	67.15
Cash & Short-Term Investments	50.3	59.72	54.91	26.21	46.52	67.15
Cash Growth	8.32%	8.76%	109.48%	-43.65%	-30.73%	-19.97%
Accounts Receivable	9.42	7.2	7.05	7.29	6.34	1.41
Other Receivables	0.15	0.3	-	-	-	3.62
Total Trade Receivables	9.57	7.5	7.05	7.29	6.34	5.03
Inventory	9	8.24	5.8	6.99	7.94	7.41
Other Current Assets	0.81	0.93	1.31	1.41	1.22	1.15
Total Current Assets	69.53	76.09	69.07	41.9	62.02	77.13
Net Property, Plant & Equipment	3.58	0.88	0.82	1.57	1.72	1.9
Other Intangible Assets	0.13	0.14	0.26	0.49	0.68	1.44
Goodwill	-	-	-	-	-	2.69
Other Long-Term Assets	0.07	0.07	0.09	-	-	-
Total Assets	73.46	77.48	70.23	43.96	64.42	86.78
Accounts Payable	2.14	1.56	1.32	0.87	2.03	3.18
Accrued Expenses	3.39	3.82	2.84	2.42	-	-
Current Portion of Long-Term Debt	4.5	-	1.74	2.1	0.52	-
Current Portion of Leases	0.07	0.21	0.26	0.26	0.24	0.25
Unearned Revenue	0.46	0.45	0.42	0.72	0.47	0.48
Other Current Liabilities	0.04	0.04	-	-	0.92	0.25
Total Current Liabilities	10.61	6.08	6.57	6.37	4.19	4.16
Long-Term Debt	-	4.5	2.92	5	6.65	-
Long-Term Leases	2.89	-	0.2	0.5	0.82	1.13
Other Long-Term Liabilities	0.53	0.47	0.12	0.86	0.76	0.88
Total Long-Term Liabilities	3.43	4.97	3.25	6.36	8.23	2
Total Liabilities	14.03	11.04	9.81	12.73	12.42	6.16
Common Stock	324.16	323.84	281.55	222.21	205.83	219.58
Additional Paid-in Capital	26.03	25.31	21.3	20.81	18.7	16.99
Accumulated Other Comprehensive Income	4.02	5.03	2.74	5.57	16.84	4.75
Retained Earnings	-294.79	-287.74	-245.17	-217.35	-189.36	-160.69
Shareholders' Equity	59.42	66.43	60.42	31.22	52	80.62
Total Liabilities & Equity	73.46	77.48	70.23	43.96	64.42	86.78
Total Debt	7.46	4.71	5.12	7.87	8.23	1.38
Net Cash (Debt)	42.83	55.01	49.79	18.35	38.29	65.78
Net Cash Growth	-22.14%	10.48%	171.40%	-52.08%	-41.79%	-20.02%
Net Cash Per Share	1.35	1.82	2.01	0.87	1.84	3.21
Book Value	59.42	66.43	60.42	31.22	52	80.62
Book Value Per Share	1.87	2.20	2.44	1.47	2.50	3.94
Tangible Book Value	59.3	66.3	60.16	30.73	51.32	76.49
Tangible Book Value Per Share	1.86	2.19	2.43	1.45	2.46	3.74

SEC Filings: 10-K · 10-Q